Pushing the boundaries in pharmaceutical hit discovery with the novel waveRAPID kinetic assay

In this application note, Creoptix demonstrates the power of waveRAPID^® in streamlining the kinetic characterization of large numbers of drug hit compounds, with results comparable to traditional SPR and high reproducibility.